advertisement
14 Costing studies; pharmacoeconomics (4)
Showing records 1 to 4
Display all abstracts in classification 14 Costing studies; pharmacoeconomics
Search within classification 14 Costing studies; pharmacoeconomics8073 A cost analysis of the prostaglandin analogs
Mick AB; Gonzalez S; Dunbar MT; McSoley J
Optometry 2002; 73: 614-619
8078 An economic analysis of switching to latanoprost from a beta-blocker or adding brimonidine or latanoprost to a beta-blocker in open-angle glaucoma or ocular hypertension
Stewart WC; Leech J; Sharpe ED; Kulze J; Ellyn J; Day DG
American Journal of Management Care 2002; 8 S240-248
8248 Health economics, economic evaluation, and glaucoma
Kobelt G
Journal of Glaucoma 2002; 11: 531-539
8009 Incidence of iris colour change in latanoprost treated eyes
Teus MA; Arranz-Marquez E; Lucea-Suescun P
British Journal of Ophthalmology 2002; 86: 1085-1088